Our Newsletters

Filter By: 
 

2012

Date Title
January 4, 2012

FDA Issues Draft Guidance, Requests Public Comments on Communication of Off-Label Information

Type: On the Subject

 

2010

Date Title
June 1, 2010

Qualifying Health-Sciences Companies Should Act Quickly to Secure Available Tax Credits and Grants for Investments in Therapeutic Discovery Projects

Type: On the Subject

April 26, 2010

Health Care Reform: Patient Protection and Affordable Care Act Expands Hospital Eligibility for 340B Program

Type: On the Subject

April 12, 2010

Health Care Reform: Substantial Fraud and Abuse and Program Integrity Measures Enacted

Type: White Papers

March 15, 2010

Increased Billing Audits Suggest Enhanced FCA Risk

Type: On the Subject

 

2009

Date Title
February 11, 2009

Proposed Legislation Prohibits Settlement Payments to Generic Drug Manufacturers

Type: On the Subject

 

2008

Date Title
July 15, 2008

PhRMA Revises Code on Interactions with Healthcare Professionals

Type: White Papers

May 29, 2008

Merck Settles Vioxx® Litigation with State Attorneys General: an Analysis

Type: White Papers

April 14, 2008

Third Circuit Decides Long-Awaited Antidepressant Drug Labeling Preemption Cases

Type: On the Subject

February 28, 2008

Supreme Court Holds That FDA Premarket Approval of Class III Medical Device Preempts State Tort Law

Type: On the Subject

January 22, 2008

FDA Issues Proposed Regulations on Supplemental Applications for Labeling Changes

Type: On the Subject

 

2007

Date Title
April 2007

International News, Issue 1, 2007

Type: International News

McDermott Will & Emery

McDermott Will and Emery